chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: was not eating; nausea and vomiting; nausea and vomiting; excruciating pain on her left shoulder arm, elbow down to her hand; lump above her left elbow; 3 red spots on her left arm which now appear like bruises; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 04-Mar-2021 and was forwarded to Moderna on 05-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of MASS (lump above her left elbow), RASH MACULAR (3 red spots on her left arm which now appear like bruises), DECREASED APPETITE (was not eating), VOMITING (nausea and vomiting) and NAUSEA (nausea and vomiting) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030MexA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, the patient experienced MASS (lump above her left elbow), RASH MACULAR (3 red spots on her left arm which now appear like bruises) and ARTHRALGIA (excruciating pain on her left shoulder arm, elbow down to her hand). On an unknown date, the patient experienced DECREASED APPETITE (was not eating), VOMITING (nausea and vomiting) and NAUSEA (nausea and vomiting). The patient was treated with PARACETAMOL (TYNELOL) ongoing since an unknown date for Arthralgia, Mass, Nausea, Vomiting and Rash macular, at an unspecified dose and frequency. At the time of the report, MASS (lump above her left elbow), RASH MACULAR (3 red spots on her left arm which now appear like bruises), DECREASED APPETITE (was not eating), VOMITING (nausea and vomiting), NAUSEA (nausea and vomiting) and ARTHRALGIA (excruciating pain on her left shoulder arm, elbow down to her hand) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Some of the liquid came out as it was coming out of his arm; A spontaneous report was received from a consumer concerning a 76 year-old, male patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced some of the liquid came out as it was coming out of his arm (inappropriate dose of vaccine administration).   The patient's medical history was not provided. No Concomitant medication was reported .  On 03 Mar 2021 ,the patient received their first of two planned doses of mRNA-1273  intramuscularly for prophylaxis of COVID-19 infection Lot  030A21A. Patient reported that the vaccine liquid came out as it was coming out from his arm and also patient felt like the lady who administered the vaccine was incorrectly administered to the patient.  No treatment was taken for the events .  Action taken with mRNA-1273 in response to the events was unknown.  The outcomes of the events were considered, some of the liquid came out as it was coming out of his arm (inappropriate dose of vaccine administration) was considered as resolved on 03 Mar 2021.; Reporter's Comments: This report refers to a case of 76 year-old, male patient who experienced non-serious unexpected event of some of the liquid came out as it was coming out of his arm (Incomplete dose administered) for mRNA-1273, lot # 030A21A. There were no reported AEs associated with this case of Incomplete dose administered.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Influenza like illness, Malaise, Myalgia
Clinical narrative: not feeling well; Arm hurting; Flu-like symptoms; aching badly; Nausea; Fever of 99.7; SHOULDER AND HIP PAIN; Muscle pains; HEADACHES; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 03-Mar-2021 and was forwarded to Moderna on 04-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (not feeling well), PAIN IN EXTREMITY (Arm hurting), INFLUENZA LIKE ILLNESS (Flu-like symptoms), PAIN (aching badly) and NAUSEA (Nausea) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MALAISE (not feeling well), PAIN IN EXTREMITY (Arm hurting), INFLUENZA LIKE ILLNESS (Flu-like symptoms), PAIN (aching badly), NAUSEA (Nausea), PYREXIA (Fever of 99.7), ARTHRALGIA (SHOULDER AND HIP PAIN), MYALGIA (Muscle pains) and HEADACHE (HEADACHES). At the time of the report, MALAISE (not feeling well), PAIN IN EXTREMITY (Arm hurting), INFLUENZA LIKE ILLNESS (Flu-like symptoms), PAIN (aching badly), NAUSEA (Nausea), PYREXIA (Fever of 99.7), ARTHRALGIA (SHOULDER AND HIP PAIN), MYALGIA (Muscle pains) and HEADACHE (HEADACHES) outcome was unknown.            Concomitant medications were not reported. The patient wanted to confirm if she can take Tylenol for the symptoms or not.   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: NNI
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Pain in extremity, Pyrexia
Clinical narrative: not feeling well; Arm hurting; Flu-like symptoms; aching badly; Nausea; Fever of 99.7; SHOULDER AND HIP PAIN; Muscle pains; HEADACHES; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 03-Mar-2021 and was forwarded to Moderna on 04-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (not feeling well), PAIN IN EXTREMITY (Arm hurting), INFLUENZA LIKE ILLNESS (Flu-like symptoms), PAIN (aching badly) and NAUSEA (Nausea) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MALAISE (not feeling well), PAIN IN EXTREMITY (Arm hurting), INFLUENZA LIKE ILLNESS (Flu-like symptoms), PAIN (aching badly), NAUSEA (Nausea), PYREXIA (Fever of 99.7), ARTHRALGIA (SHOULDER AND HIP PAIN), MYALGIA (Muscle pains) and HEADACHE (HEADACHES). At the time of the report, MALAISE (not feeling well), PAIN IN EXTREMITY (Arm hurting), INFLUENZA LIKE ILLNESS (Flu-like symptoms), PAIN (aching badly), NAUSEA (Nausea), PYREXIA (Fever of 99.7), ARTHRALGIA (SHOULDER AND HIP PAIN), MYALGIA (Muscle pains) and HEADACHE (HEADACHES) outcome was unknown.            Concomitant medications were not reported. The patient wanted to confirm if she can take Tylenol for the symptoms or not.   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: NNI
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: numbness in lower face; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 03-Mar-2021 and was forwarded to Moderna on 03-Mar-2021.    This spontaneous case was reported by an other health care professional and describes the occurrence of HYPOAESTHESIA (numbness in lower face) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 013A21A) for COVID-19 vaccination.     No medical history was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Mar-2021, the patient experienced HYPOAESTHESIA (numbness in lower face). At the time of the report, HYPOAESTHESIA (numbness in lower face) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient was taking unspecified antidepressants as concomitant medications.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Injection site erythema, Injection site swelling, Nasopharyngitis, Pruritus
Clinical narrative: It's itchy; It never gets cold; A lot of chilling for the first couple of days, it was really super cold; Square slightly swollen and red; Square slightly swollen and red; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 04-Mar-2021 and was forwarded to Moderna on 04-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (It's itchy), NASOPHARYNGITIS (It never gets cold), CHILLS (A lot of chilling for the first couple of days, it was really super cold), INJECTION SITE SWELLING (Square slightly swollen and red) and INJECTION SITE ERYTHEMA (Square slightly swollen and red) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0957A1A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (It's itchy), NASOPHARYNGITIS (It never gets cold), CHILLS (A lot of chilling for the first couple of days, it was really super cold), INJECTION SITE SWELLING (Square slightly swollen and red) and INJECTION SITE ERYTHEMA (Square slightly swollen and red). The patient was treated with ALCOHOL ongoing since an unknown date for Pruritus, at an unspecified dose and frequency. At the time of the report, PRURITUS (It's itchy), NASOPHARYNGITIS (It never gets cold), CHILLS (A lot of chilling for the first couple of days, it was really super cold), INJECTION SITE SWELLING (Square slightly swollen and red) and INJECTION SITE ERYTHEMA (Square slightly swollen and red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant and treatment details not reported.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Eye pain, Fatigue, Influenza like illness, Pyrexia
Clinical narrative: flue like symptoms; muscle ache on their eyes; Fever; Fatigue; chills; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flue like symptoms), EYE PAIN (muscle ache on their eyes), PYREXIA (Fever), FATIGUE (Fatigue) and CHILLS (chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (flue like symptoms), EYE PAIN (muscle ache on their eyes), PYREXIA (Fever), FATIGUE (Fatigue) and CHILLS (chills). On 27-Feb-2021, INFLUENZA LIKE ILLNESS (flue like symptoms), PYREXIA (Fever) and CHILLS (chills) had resolved. At the time of the report, EYE PAIN (muscle ache on their eyes) and FATIGUE (Fatigue) outcome was unknown.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable  No concomitant medications reported. No treatment reported
Sex: M
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Nausea, Pyrexia
Clinical narrative: diarrhea; fever of 101.5 degrees; nausea; chills; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 04-Mar-2021 and was forwarded to Moderna on 04-Mar-2021.    This spontaneous case was reported by an other caregiver and describes the occurrence of DIARRHOEA (diarrhea), PYREXIA (fever of 101.5 degrees), NAUSEA (nausea) and CHILLS (chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (diarrhea), PYREXIA (fever of 101.5 degrees), NAUSEA (nausea) and CHILLS (chills). At the time of the report, DIARRHOEA (diarrhea), PYREXIA (fever of 101.5 degrees), NAUSEA (nausea) and CHILLS (chills) outcome was unknown.            Concomitant medications and treatment details not reported.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Hypersensitivity, Pyrexia, Vaccination site erythema, Vaccination site pain
Clinical narrative: at site of injection, allergy appeared; hot; burning sensation; red; pain; Fever/Now, I have something mild; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 04-Mar-2021 and was forwarded to Moderna on 04-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (at site of injection, allergy appeared), VACCINATION SITE WARMTH (hot), BURNING SENSATION (burning sensation), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE PAIN (pain) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma. Concomitant products included GABAPENTIN (NEURONTIN), LEVOTHYROXINE SODIUM (SYNTHROID) and CIRCUPLEX for an unknown indication.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERSENSITIVITY (at site of injection, allergy appeared), VACCINATION SITE WARMTH (hot), BURNING SENSATION (burning sensation), VACCINATION SITE ERYTHEMA (red), VACCINATION SITE PAIN (pain) and PYREXIA (Fever/Now, I have something mild). At the time of the report, HYPERSENSITIVITY (at site of injection, allergy appeared), VACCINATION SITE WARMTH (hot), BURNING SENSATION (burning sensation), VACCINATION SITE ERYTHEMA (red), VACCINATION SITE PAIN (pain) and PYREXIA (Fever/Now, I have something mild) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient reported that she received treatment with unspecified pills for allergies along with hydrocortisone cream with aloe. Following treatment, did not have her arm as hot as before and also she did not feel discomfort in her arm.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: at site of injection, allergy appeared; hot; burning sensation; red; pain; Fever/Now, I have something mild; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 04-Mar-2021 and was forwarded to Moderna on 04-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (at site of injection, allergy appeared), VACCINATION SITE WARMTH (hot), BURNING SENSATION (burning sensation), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE PAIN (pain) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma. Concomitant products included GABAPENTIN (NEURONTIN), LEVOTHYROXINE SODIUM (SYNTHROID) and CIRCUPLEX for an unknown indication.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERSENSITIVITY (at site of injection, allergy appeared), VACCINATION SITE WARMTH (hot), BURNING SENSATION (burning sensation), VACCINATION SITE ERYTHEMA (red), VACCINATION SITE PAIN (pain) and PYREXIA (Fever/Now, I have something mild). At the time of the report, HYPERSENSITIVITY (at site of injection, allergy appeared), VACCINATION SITE WARMTH (hot), BURNING SENSATION (burning sensation), VACCINATION SITE ERYTHEMA (red), VACCINATION SITE PAIN (pain) and PYREXIA (Fever/Now, I have something mild) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient reported that she received treatment with unspecified pills for allergies along with hydrocortisone cream with aloe. Following treatment, did not have her arm as hot as before and also she did not feel discomfort in her arm.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Diarrhea; This spontaneous case was reported by a physician and describes the occurrence of DIARRHOEA (Diarrhea) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced DIARRHOEA (Diarrhea). At the time of the report, DIARRHOEA (Diarrhea) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported by investigator I V fluids used as a treatment.
Age: 58.0
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site swelling
Clinical narrative: swelling in left arm; itching in left arm; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 04-Mar-2021 and was forwarded to Moderna on 05-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (swelling in left arm) and VACCINATION SITE PRURITUS (itching in left arm) in a 58-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure and Thyroid disorder. Concomitant products included METFORMIN for an unknown indication.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (swelling in left arm) and VACCINATION SITE PRURITUS (itching in left arm). At the time of the report, VACCINATION SITE SWELLING (swelling in left arm) and VACCINATION SITE PRURITUS (itching in left arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient was taking unspecified medications for blood pressure and thyroid.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: red; swollen; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 04-Mar-2021 and was forwarded to Moderna on 05-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (red) and INJECTION SITE SWELLING (swollen) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024m20a) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced INJECTION SITE ERYTHEMA (red) and INJECTION SITE SWELLING (swollen). At the time of the report, INJECTION SITE ERYTHEMA (red) and INJECTION SITE SWELLING (swollen) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant and treatment medications were not reported. Reportedly, the reaction had gone away.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: Sore arm; Nagging headache; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 03-Mar-2021 and was forwarded to Moderna on 03-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and HEADACHE (Nagging headache) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included AMLODIPINE and ESOMEPRAZOLE MAGNESIUM TRIHYDRATE (NEXIUM [ESOMEPRAZOLE MAGNESIUM TRIHYDRATE]) for an unknown indication.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm) and HEADACHE (Nagging headache). At the time of the report, PAIN IN EXTREMITY (Sore arm) and HEADACHE (Nagging headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient wanted to confirm if he could take Motrin or something else for headache and pain. Reportedly, he was shocked to hear that the vaccine has not been approved by the FDA and said he needed to call his lawyer,  and needed to go to the news with this. Then his mother explained to him that the vaccine was approved. The agent read the disclaimer again to both (son and mother); the mother was able to understand the difference between, "approved", "authorized" and "Emergency Use". The patient then calmed down.  Most recent FOLLOW-UP information includes: The patient was feeling better and did not want any other follow-ups.   Reporter did not allow further contact
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Diarrhoea, Nausea
Clinical narrative: extreme stomach cramps; diarrhea; nausea; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (extreme stomach cramps), DIARRHOEA (diarrhea) and NAUSEA (nausea) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included POTASSIUM and VITAMINS NOS for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 04-Mar-2021, the patient experienced ABDOMINAL PAIN UPPER (extreme stomach cramps), DIARRHOEA (diarrhea) and NAUSEA (nausea). At the time of the report, ABDOMINAL PAIN UPPER (extreme stomach cramps), DIARRHOEA (diarrhea) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Relevant concomitant medications also included blood pressure pills and cholesterol pills. Treatment information included water and Gatorade.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: "absolutely exhausted"; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE ("absolutely exhausted") in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020L20A and 023M20A) for COVID-19 vaccination.     Concurrent medical conditions included Supraventricular tachycardia, Asthma, Arthritis, Hypothyroidism, Hypertension and Hyperlipidemia. Concomitant products included METOPROLOL, PRAVASTATIN, LEVOTHYROXINE and HCTZ for an unknown indication.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced FATIGUE ("absolutely exhausted"). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, FATIGUE ("absolutely exhausted") outcome was unknown.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Vomiting
Clinical narrative: throwing up; headache; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (throwing up) and HEADACHE (headache) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetic.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced HEADACHE (headache). On 04-Mar-2021, the patient experienced VOMITING (throwing up). At the time of the report, VOMITING (throwing up) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Poor quality sleep, Psychomotor hyperactivity
Clinical narrative: Felt like he drank a lot of coffee and was all hyped up; can't stay asleep/Could not sleep for more than 2-3 hours /couldn't sleep well; slight headache; This spontaneous case was reported by a consumer and describes the occurrence of PSYCHOMOTOR HYPERACTIVITY (Felt like he drank a lot of coffee and was all hyped up), POOR QUALITY SLEEP (can't stay asleep/Could not sleep for more than 2-3 hours /couldn't sleep well) and HEADACHE (slight headache) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced PSYCHOMOTOR HYPERACTIVITY (Felt like he drank a lot of coffee and was all hyped up), POOR QUALITY SLEEP (can't stay asleep/Could not sleep for more than 2-3 hours /couldn't sleep well) and HEADACHE (slight headache). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] at an unspecified dose and frequency. At the time of the report, PSYCHOMOTOR HYPERACTIVITY (Felt like he drank a lot of coffee and was all hyped up), POOR QUALITY SLEEP (can't stay asleep/Could not sleep for more than 2-3 hours /couldn't sleep well) and HEADACHE (slight headache) outcome was unknown.            No relevant concomitant medication was reported.   This case was linked to MOD21-044585 (Patient Link).
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Decreased appetite, Diarrhoea, Fatigue, Nausea
Clinical narrative: Lost my appetite; Weakness; Diarrhea; Bruising in right arm; Nausea; Feeling exhausted; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Lost my appetite), ASTHENIA (Weakness), DIARRHOEA (Diarrhea), VACCINATION SITE BRUISING (Bruising in right arm) and NAUSEA (Nausea) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included METFORMIN for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Feb-2021, the patient experienced DECREASED APPETITE (Lost my appetite), ASTHENIA (Weakness), DIARRHOEA (Diarrhea), VACCINATION SITE BRUISING (Bruising in right arm), NAUSEA (Nausea) and FATIGUE (Feeling exhausted). The patient was treated with ACETAMINOPHEN for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, DECREASED APPETITE (Lost my appetite), ASTHENIA (Weakness), DIARRHOEA (Diarrhea), VACCINATION SITE BRUISING (Bruising in right arm), NAUSEA (Nausea) and FATIGUE (Feeling exhausted) was resolving.            Concomitant medications also include blood pressure medicine and thyroid medicine of unspecified dose and frequency.  Treatment medication included Acetaminophen unspecified strength x2 doses on Sunday, 28 February 2021.   Reporter did not allow further contact
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site bruising
Clinical narrative: Lost my appetite; Weakness; Diarrhea; Bruising in right arm; Nausea; Feeling exhausted; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Lost my appetite), ASTHENIA (Weakness), DIARRHOEA (Diarrhea), VACCINATION SITE BRUISING (Bruising in right arm) and NAUSEA (Nausea) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included METFORMIN for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Feb-2021, the patient experienced DECREASED APPETITE (Lost my appetite), ASTHENIA (Weakness), DIARRHOEA (Diarrhea), VACCINATION SITE BRUISING (Bruising in right arm), NAUSEA (Nausea) and FATIGUE (Feeling exhausted). The patient was treated with ACETAMINOPHEN for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, DECREASED APPETITE (Lost my appetite), ASTHENIA (Weakness), DIARRHOEA (Diarrhea), VACCINATION SITE BRUISING (Bruising in right arm), NAUSEA (Nausea) and FATIGUE (Feeling exhausted) was resolving.            Concomitant medications also include blood pressure medicine and thyroid medicine of unspecified dose and frequency.  Treatment medication included Acetaminophen unspecified strength x2 doses on Sunday, 28 February 2021.   Reporter did not allow further contact
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Laziness, Malaise, Pain in extremity
Clinical narrative: headache; fatigue; Silent migraine; Lazy; Sore arm; lights around eyes; doesn't feel like doing anything; This spontaneous case was reported by a consumer and describes the occurrence of TYPICAL AURA WITHOUT HEADACHE (Silent migraine), LAZINESS (Lazy), PAIN IN EXTREMITY (Sore arm), PHOTOPSIA (lights around eyes) and MALAISE (doesn't feel like doing anything) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 04-Mar-2021, the patient experienced TYPICAL AURA WITHOUT HEADACHE (Silent migraine), LAZINESS (Lazy), PAIN IN EXTREMITY (Sore arm), PHOTOPSIA (lights around eyes) and MALAISE (doesn't feel like doing anything). At the time of the report, TYPICAL AURA WITHOUT HEADACHE (Silent migraine), LAZINESS (Lazy), PAIN IN EXTREMITY (Sore arm), PHOTOPSIA (lights around eyes) and MALAISE (doesn't feel like doing anything) outcome was unknown.            Action taken with mRNA-1273(Moderna Covid-19 Vaccine) was not applicable. No concomitant medications provided No treatment was reported   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Non-significant information.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Photopsia, Typical aura without headache
Clinical narrative: headache; fatigue; Silent migraine; Lazy; Sore arm; lights around eyes; doesn't feel like doing anything; This spontaneous case was reported by a consumer and describes the occurrence of TYPICAL AURA WITHOUT HEADACHE (Silent migraine), LAZINESS (Lazy), PAIN IN EXTREMITY (Sore arm), PHOTOPSIA (lights around eyes) and MALAISE (doesn't feel like doing anything) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 04-Mar-2021, the patient experienced TYPICAL AURA WITHOUT HEADACHE (Silent migraine), LAZINESS (Lazy), PAIN IN EXTREMITY (Sore arm), PHOTOPSIA (lights around eyes) and MALAISE (doesn't feel like doing anything). At the time of the report, TYPICAL AURA WITHOUT HEADACHE (Silent migraine), LAZINESS (Lazy), PAIN IN EXTREMITY (Sore arm), PHOTOPSIA (lights around eyes) and MALAISE (doesn't feel like doing anything) outcome was unknown.            Action taken with mRNA-1273(Moderna Covid-19 Vaccine) was not applicable. No concomitant medications provided No treatment was reported   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Non-significant information.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: Itching; Got a rash on my chest; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching) and RASH (Got a rash on my chest) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced PRURITUS (Itching) and RASH (Got a rash on my chest). The patient was treated with CORTISONE at an unspecified dose and frequency and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, PRURITUS (Itching) and RASH (Got a rash on my chest) outcome was unknown.            No relevant concomitant medications were reported.  Other treatment information included some shot that doctor gave to the patient.  Action taken with mRNA-1273 in response to the events was not applicable.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling
Clinical narrative: Swollen arm; Pain in arm; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen arm) and PAIN IN EXTREMITY (Pain in arm) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20a) for COVID-19 vaccination.     The patient's past medical history included Shoulder replacement. Concurrent medical conditions included Drug allergy (Sulpha).    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced PERIPHERAL SWELLING (Swollen arm) and PAIN IN EXTREMITY (Pain in arm). The patient was treated with PARACETAMOL (TYLENOL) for Swollen arm and Pain in arm, at an unspecified dose and frequency. In February 2021, PERIPHERAL SWELLING (Swollen arm) and PAIN IN EXTREMITY (Pain in arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information included Tylenol.   This case was linked to MOD-2021-034898 (Patient Link).
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling hot, Nausea, Peripheral swelling, Vaccination site discolouration
Clinical narrative: very dark discoloration appeared at the injection site; painful to touch; Feeling of warmth; Swollen arm; Nauseous; Vomited; Chills; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (very dark discoloration appeared at the injection site), FEELING HOT (Feeling of warmth), PERIPHERAL SWELLING (Swollen arm), NAUSEA (Nauseous) and VOMITING (Vomited) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027a21a and 031L20a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Shoulder replacement. Concurrent medical conditions included Drug allergy (Sulfa).   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced FEELING HOT (Feeling of warmth), PERIPHERAL SWELLING (Swollen arm), NAUSEA (Nauseous), VOMITING (Vomited) and CHILLS (Chills). On an unknown date, the patient experienced VACCINATION SITE DISCOLOURATION (very dark discoloration appeared at the injection site) and VACCINATION SITE PAIN (painful to touch). The patient was treated with Manual therapy (Ice) for Peripheral swelling. At the time of the report, VACCINATION SITE DISCOLOURATION (very dark discoloration appeared at the injection site) was resolving and FEELING HOT (Feeling of warmth), PERIPHERAL SWELLING (Swollen arm), NAUSEA (Nauseous), VOMITING (Vomited), CHILLS (Chills) and VACCINATION SITE PAIN (painful to touch) outcome was unknown.            Treatment information included Tylenol. Ice   This case was linked to MOD-2021-034896 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Follow up TCR received on 30-Apr-2021. Added events and events outcome.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vomiting
Clinical narrative: very dark discoloration appeared at the injection site; painful to touch; Feeling of warmth; Swollen arm; Nauseous; Vomited; Chills; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (very dark discoloration appeared at the injection site), FEELING HOT (Feeling of warmth), PERIPHERAL SWELLING (Swollen arm), NAUSEA (Nauseous) and VOMITING (Vomited) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027a21a and 031L20a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Shoulder replacement. Concurrent medical conditions included Drug allergy (Sulfa).   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced FEELING HOT (Feeling of warmth), PERIPHERAL SWELLING (Swollen arm), NAUSEA (Nauseous), VOMITING (Vomited) and CHILLS (Chills). On an unknown date, the patient experienced VACCINATION SITE DISCOLOURATION (very dark discoloration appeared at the injection site) and VACCINATION SITE PAIN (painful to touch). The patient was treated with Manual therapy (Ice) for Peripheral swelling. At the time of the report, VACCINATION SITE DISCOLOURATION (very dark discoloration appeared at the injection site) was resolving and FEELING HOT (Feeling of warmth), PERIPHERAL SWELLING (Swollen arm), NAUSEA (Nauseous), VOMITING (Vomited), CHILLS (Chills) and VACCINATION SITE PAIN (painful to touch) outcome was unknown.            Treatment information included Tylenol. Ice   This case was linked to MOD-2021-034896 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Follow up TCR received on 30-Apr-2021. Added events and events outcome.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Vaccination site erythema, Vaccination site pain
Clinical narrative: red and itchy mark at the injection site; arm from first dose still redness, not as bad; first injection hurt the worst; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (red and itchy mark at the injection site), VACCINATION SITE ERYTHEMA (arm from first dose still redness, not as bad) and VACCINATION SITE PAIN (first injection hurt the worst) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE ERYTHEMA (red and itchy mark at the injection site), VACCINATION SITE ERYTHEMA (arm from first dose still redness, not as bad) and VACCINATION SITE PAIN (first injection hurt the worst). At the time of the report, INJECTION SITE ERYTHEMA (red and itchy mark at the injection site), VACCINATION SITE ERYTHEMA (arm from first dose still redness, not as bad) and VACCINATION SITE PAIN (first injection hurt the worst) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant information were not provided by the reporter. Treatment information were not provided by the reporter.   This case was linked to MOD-2021-060419 (Patient Link).   Reporter did not allow further contact
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: injection site pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (injection site pain) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 20-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2021, the patient experienced VACCINATION SITE PAIN (injection site pain). At the time of the report, VACCINATION SITE PAIN (injection site pain) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported by investigator  No treatment medications provided by the reporter.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
Sex: M
Vaccine: COVID19
Symptoms: Poor quality sleep
Clinical narrative: trouble sleeping; This spontaneous case was reported by a consumer and describes the occurrence of POOR QUALITY SLEEP (trouble sleeping) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced POOR QUALITY SLEEP (trouble sleeping). At the time of the report, POOR QUALITY SLEEP (trouble sleeping) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD-2021-034892 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: No specific follow-up information recorded.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: soreness at the injection site; soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of the first episode of VACCINATION SITE PAIN (soreness at the injection site) and the second episode of VACCINATION SITE PAIN (soreness at the injection site) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced the first episode of VACCINATION SITE PAIN (soreness at the injection site). On 04-Mar-2021, the patient experienced the second episode of VACCINATION SITE PAIN (soreness at the injection site). At the time of the report, last episode of VACCINATION SITE PAIN (soreness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site pain
Clinical narrative: Soreness at upper arm; Soreness around injection site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness at upper arm) and VACCINATION SITE PAIN (Soreness around injection site) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Soreness at upper arm) and VACCINATION SITE PAIN (Soreness around injection site). At the time of the report, PAIN IN EXTREMITY (Soreness at upper arm) and VACCINATION SITE PAIN (Soreness around injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided. Treatment details were not provided.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Nausea, Pyrexia
Clinical narrative: chills; headache; nausea; fever; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), HEADACHE (headache), NAUSEA (nausea) and PYREXIA (fever) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in November 2020.    In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced CHILLS (chills), HEADACHE (headache), NAUSEA (nausea) and PYREXIA (fever). At the time of the report, CHILLS (chills), NAUSEA (nausea) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment information was reported.